Healthequity Inc (NASDAQ:HQY) insider Stephen Neeleman sold 40,169 shares of the stock in a transaction dated Thursday, March 16th. The shares were sold at an average price of $45.96, for a total transaction of $1,846,167.24. Following the completion of the sale, the insider now owns 1,000 shares of the company’s stock, valued at $45,960. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Stephen Neeleman also recently made the following trade(s):

  • On Tuesday, February 28th, Stephen Neeleman sold 1,600 shares of Healthequity stock. The shares were sold at an average price of $44.02, for a total transaction of $70,432.00.
  • On Monday, February 27th, Stephen Neeleman sold 215 shares of Healthequity stock. The shares were sold at an average price of $44.00, for a total transaction of $9,460.00.

Shares of Healthequity Inc (NASDAQ:HQY) traded up 0.033% during midday trading on Monday, hitting $45.585. 342,132 shares of the company’s stock were exchanged. Healthequity Inc has a one year low of $21.90 and a one year high of $49.25. The firm has a market cap of $2.71 billion, a PE ratio of 108.536 and a beta of 1.94. The stock’s 50-day moving average price is $44.16 and its 200 day moving average price is $40.32.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Your IP Address:

HQY has been the subject of a number of recent research reports. Zacks Investment Research cut shares of Healthequity from a “hold” rating to a “sell” rating in a research report on Monday, December 12th. Chardan Capital assumed coverage on shares of Healthequity in a research report on Tuesday, December 13th. They set a “buy” rating and a $50.00 price objective for the company. KeyCorp assumed coverage on shares of Healthequity in a research report on Monday, January 23rd. They set an “overweight” rating and a $60.00 price objective for the company. Oppenheimer Holdings Inc. assumed coverage on shares of Healthequity in a research report on Monday, March 13th. They set an “outperform” rating and a $58.00 price objective for the company. Finally, Wells Fargo & Co assumed coverage on shares of Healthequity in a research report on Tuesday, March 14th. They set an “outperform” rating for the company. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Healthequity currently has a consensus rating of “Buy” and an average price target of $41.82.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. O Shaughnessy Asset Management LLC purchased a new position in Healthequity during the fourth quarter worth about $108,000. Sowell Financial Services LLC purchased a new position in Healthequity during the fourth quarter worth about $203,000. SG Americas Securities LLC purchased a new position in Healthequity during the third quarter worth about $220,000. Aperio Group LLC purchased a new position in Healthequity during the third quarter worth about $227,000. Finally, Mark Sheptoff Financial Planning LLC purchased a new position in Healthequity during the third quarter worth about $231,000. Institutional investors own 89.22% of the company’s stock.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

5 Day Chart for NASDAQ:HQY

Receive News & Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.